Probiotic dietary supplements are among the most demanding product groups in microbiological quality control — and for one simple but decisive reason: the microbiological component is not a contamination risk to be eliminated, but the very core of the product itself. This places quality control in a dual role: on one hand, the declared microorganisms must be demonstrated at a defined, viable concentration. On the other hand, pathogens and unwanted accompanying flora must not exceed specified limits.
When plant-based components are added — such as fennel or peppermint to support digestion — the situation becomes even more complex. Many plant extracts carry their own antimicrobial activity, which can specifically interfere with testing methods. This article explains what matters in this context.
Regulatory Framework
Probiotic dietary supplements fall primarily under food law. The legal basis is formed by the LFGB (German Food and Feed Code) and Regulation (EC) No. 178/2002 as the general safety framework. Regulation (EC) No. 2073/2005 defines microbiological criteria for certain food categories; where applicable, these can also be applied to dietary supplements. Since no specific microbiological limits exist for many products, limits are established in practice on the basis of a product-specific risk assessment.
Microbiological testing is typically carried out methodologically according to the relevant ISO procedures.
If probiotics are placed on the market as medicinal products, the requirements of the European Pharmacopoeia (Ph. Eur.) apply. Particularly relevant are the general acceptance criteria for non-sterile preparations under Ph. Eur. 5.1.4, as well as the test chapters on microbial enumeration and detection of specified microorganisms under Ph. Eur. 2.6.12 and 2.6.13. For plant-based components in oral medicinal products, Ph. Eur. 2.6.31 is additionally consulted.
In practice, both regulatory contexts frequently occur simultaneously — sometimes even within a single product portfolio. A clear assignment is therefore essential as early as the development phase.
Why the Matrix Plays a Special Role in Probiotics
Many plant-based ingredients used in combination with probiotics carry their own antimicrobial activity — and this is, first and foremost, a quality attribute. Essential oils from fennel, anise, or caraway; phenolic compounds from sage, thyme, or peppermint; tannins from plant extracts such as witch hazel or blackberry leaf; and pungent compounds from ginger or turmeric are well-known examples.
However, this very activity can distort microbiological testing in two directions: on one hand, the declared microorganisms may be damaged during sample preparation, leading to an underestimation of the viable cell count. On the other hand, false-negative results can occur in pathogen testing if the inhibitory effect of the matrix is not adequately neutralized during enrichment steps.
In probiotic dietary supplements, germ-reduced extracts are predominantly used, meaning the microbial background load at the raw material level is generally low. The decisive matrix effect thus shifts away from the accompanying flora toward the concentrated active fraction. Alcoholic extracts may contain residual alcohol or concentrated essential oils that enhance the antimicrobial effect. But even aqueous or glycerin-based extracts can exert a relevant inhibitory effect through tannins or phenolic compounds. Without product-specific methodological safeguards, there is a real risk of distorted results or false-negative findings in such cases.
Method Spectrum at PhytoLab
Microbiological testing of probiotic dietary supplements with plant-based matrices requires a coordinated range of methods that jointly addresses quantification, pathogen detection, and matrix assessment. PhytoLab has an established method portfolio for probiotic products and many years of experience in handling plant-based matrices with antimicrobial activity.
The range of services includes, among others:
- Quantification of the declared probiotic microorganisms using culture-based enumeration methods on selective and differentiating media — for example, for Bacillus coagulans or mesophilic lactic acid bacteria in accordance with ISO 15214
- Food microbiological testing for Salmonella spp., Listeria monocytogenes, Enterobacteriaceae, Escherichia coli, Bacillus cereus, Staphylococcus aureus, as well as yeasts and moulds, using validated, established, and standard-based procedures
- Testing in the pharmaceutical context according to Ph. Eur. 2.6.12, 2.6.13, and 2.6.31, supplemented where necessary with matrix-adapted variants
- Product-specific suitability testing with transparent and audit-proof documentation
- Consultation on method selection, for example in the context of formulation development, supplier changes, or adjustments to the microorganisms used
These testing concepts are particularly relevant for new product launches, formulation adjustments, changes in the supply chain, and generally for any combination of probiotic and plant-based components.
Conclusion
From a microbiological standpoint, probiotics in plant-based matrices are not a standard matrix. The simultaneous requirement to quantitatively capture viable target microorganisms while reliably excluding unwanted microorganisms demands a testing concept that consistently accounts for the matrix effect.
Experience with antimicrobially active plant-based matrices and a correspondingly tailored method spectrum are the foundation for reliable results and a scientifically sound assessment of microbiological quality.
